PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden

Journal of the Neurological Sciences

Volumn 263, Issue 1-2, 2007, Pages 113-117

  Kostulas, Konstantinos ^a   Gretarsdottir, Solveig ^b   Kostulas, Vasilios ^a   Manolescu, Andrei ^b   Helgadottir, Anna ^b   Thorleifsson, Gudmar ^b   Gudmundsson, Larus J ^b   Thorsteinsdottir, Unnur ^b   Gulcher, Jeffrey R ^b   Stefansson, Kari ^b   Hillert, Jan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DECODE GENETICS   (Iceland)

Author keywords

ALOX5AP; Genetics; Ischemic stroke; PDE4D

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV D; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; EMBOLISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; SWEDEN;

AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CEREBROVASCULAR DISORDERS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SWEDEN; VARIATION (GENETICS);

EID: 35648968166     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.06.042     Document Type: Article

References (20)

1. Gretarsdottir S., Thorleifsson G., Reynisdottir S.T., Manolescu A., Jonsdottir S., Jonsdottir T., Gudmundsdottir T., et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35 2 (Oct 2003) 131-138
2. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 3 (Mar 2004) 233-239
3. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24 (1993) 35-41
4. Amundadottir L.T., Sulem P., Gudmundsson J., Helgason A., Baker A., Agnarsson B.A., et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 7 (May 2006)
5. Asplund K., et al., for the Riks-Stroke Collaboration. Riks-Stroke-a Swedish national quality register for stroke care. Cerebrovasc Dis 15 (2003) 5-7 (Suppl)
6. Lovett J.K., Coull A.J., and Rothwell P.M. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 62 4 (Feb 24 2004) 569-573
7. Helgadottir A., Gretarsdottir S., St Clair D., Manolescu A., Cheung J., Thorleifsson G., et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 76 3 (Mar 2005) 505-509
8. Lohmussaar E., Gschwendtner A., Mueller J.C., Org T., Wichmann E., Hamann G., et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 36 4 (Apr 2005) 731-736
9. Bevan S., Porteous L., Sitzer M., and Markus H.S. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 36 5 (May 2005) 949-953
10. Nilsson-Ardnor S., Wiklund P.G., Lindgren P., Nilsson A.K., Janunger T., Escher S.A., et al. Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population. Stroke 36 8 (Aug 2005) 1666-1671
11. Meschia J.F., Brott T.G., Brown Jr. R.D., Crook R., Worrall B.B., Kissela B., et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 58 3 (Sep 2005) 351-361
12. Saleheen D., Bukhari S., Haider S.R., Nazir A., Khanum S., Shafqat S., et al. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population. Stroke 36 10 (Oct 2005) 2275-2277
13. van Rijn M.J., Slooter A.J., Schut A.F., Isaacs A., Aulchenko Y.S., Snijders P.J., et al. Familial aggregation, the PDE4D gene, and ischemic stroke in a genetically isolated population. Neurology (Sep 14 2005)
14. Nakayama T., Asai S., Sato N., and Soma M. Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese: a case-control study. Stroke 37 1 (Jan 2006) 69-76
15. Woo D., Kaushal R., Kissela B., Sekar P., Wolujewicz M., Pal P., et al. Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke 37 2 (Feb 2006) 371-376
16. Kuhlenbaumer G., Berger K., Huge A., Lange E., Kessler C., John U., et al. Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort. J Neurol Neurosurg Psychiatry 77 4 (Apr 2006) 521-524
17. Brophy V.H., Ro S.K., Rhees B.K., Lui L.Y., Lee J.M., Umblas N., et al. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status. Stroke (May 4 2006)
18. Zee R.Y., Brophy V.H., Cheng S., Hegener H.H., Erlich H.A., and Ridker P.M. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation. Stroke 37 8 (Aug 2006) 2012-2017
19. Staton J.M., Sayer M.S., Hankey G.J., Attia J., Thakkinstian A., Yi Q., et al. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry 77 9 (Sep 2006) 1067-1069
20. Song Q., Cole J.W., O'Connell J.R., Stine O.C., Gallagher M., Giles W.H., et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet 15 16 (Aug 15 2006) 2468-2478